What is the average price of liraglutide exports from India?

The average unit price for liraglutide exports from India is $35.91 USD per unit, with prices ranging from $0.00 to $1000.00 depending on formulation, packaging, and order volume. The total market is valued at $4.3M across 416 shipments.

Which ports handle liraglutide exports from India?

The primary ports for liraglutide exports from India are SAHAR AIR (20.4% of shipments), HYDERABAD ACC (INHYD4) (18.3% of shipments), HYDERABAD AIR (15.9% of shipments), SAHAR AIR CARGO ACC (INBOM4) (7.5% of shipments), HAZIRA PORT SURAT ICD (7.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Why is India a leading exporter of liraglutide?

India is one of the world's leading exporters of liraglutide due to its large base of 53 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports liraglutide to 36 countries, demonstrating 18% global market coverage.

What certifications do Indian liraglutide exporters need?

Indian liraglutide exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

How many buyers import liraglutide from India?

There are 121 registered buyers importing liraglutide from India, spread across 36 countries. The repeat buyer rate is 58.7%, indicating strong long-term trade relationships and consistent product quality.

What is the market share of the top liraglutide supplier from India?

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading liraglutide exporter from India with a market share of 52.6% and total export value of $2.3M across 15 shipments. The top 5 suppliers together control 98.1% of total export value.

Liraglutide

India Pharmaceutical Trade Intelligence

$4.3M53 Suppliers36 CountriesHS 30049099

ExportsIndia → BELGIUM52.7%India → SOUTH AFRICA32.6%

ImportsDENMARK → India$157.8M GREECE → India$1.4M

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: YUSEN LOGISTICS

Liraglutide Export Data from India (2026) — Suppliers, Buyers & Trade Stats | TransData Nexus | TransData Nexus

How India Exports Liraglutide to the World

Q: Who are the top liraglutide exporters from India?

The top liraglutide exporters from India are: 1. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $2.3M (52.6% market share); 2. ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI — $1.9M (43.9% market share); 3. LUPIN LIMITED — $35.4K (0.8% market share); 4. ABBOTT INDIA LIMITED — $20.0K (0.5% market share); 5. ONESOURCE SPECIALTY PHARMA LIMITED — $11.7K (0.3% market share). Together they account for 98.1% of India's total liraglutide export value.

Q: What is the total export value of liraglutide from India?

The total export value of liraglutide from India is $4.3M USD, recorded across 416 shipment transactions from 53 active exporters to 36 destination countries. The average shipment value is $10.3K.

Q: Which countries import liraglutide from India?

India exports liraglutide to 36 countries worldwide. The top importing countries are: BELGIUM (52.7% share, $2.3M), SOUTH AFRICA (32.6% share, $1.4M), HONG KONG (7.6% share, $324.7K), SAUDI ARABIA (3.6% share, $152.5K), UNITED STATES (0.7% share, $31.3K). These five markets account for 97.2% of total export value.

Q: What is the HS code for liraglutide exports from India?

The primary HS code for liraglutide exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Between 2022 and 2026, India exported $4.3M worth of liraglutide across 416 verified shipments to 36 countries — covering 18% of world markets in the Diabetes & Endocrine segment. The largest destination is BELGIUM (52.7%). SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 52.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Liraglutide export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Liraglutide export data snapshot — $4.3M · 53 exporters · 36 countriesTransData Nexus · Indian Customs Data

Top Liraglutide Exporters from India

53 active exporters · Ranked by export value

View all 53 →

Top Liraglutide Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$2.3M	15	4	52.6%
2	ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI

Top Countries Importing Liraglutide from India

36 destination markets · Ranked by import value

All 36 countries →

Top Countries Importing Liraglutide from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	BELGIUM	$2.3M	52.7%
2	SOUTH AFRICA	$1.4M	32.6%
3	HONG KONG	$324.7K	7.6%
4	SAUDI ARABIA	$152.5K	3.6%
5	UNITED STATES	$31.3K	0.7%
6	NEPAL	$20.0K	0.5%
7	BRAZIL	$13.1K	0.3%
8	SPAIN	$10.7K	0.3%
9	UNITED ARAB EMIRATES	$9.8K	0.2%
10	ITALY	$9.2K	0.2%

BELGIUM is India's largest liraglutide export destination, absorbing 52.7% of total exports worth $2.3M. The top 5 importing countries — BELGIUM, SOUTH AFRICA, HONG KONG, SAUDI ARABIA, UNITED STATES — together account for 97.2% of India's total liraglutide export value. The remaining 31 destination countries collectively receive the other 2.8%, indicating a focused distribution strategy targeting key markets.

Who Supplies Liraglutide to India?

14 origin countries · Total import value: $161.1M

India imports liraglutide from 14 countries with a combined import value of $161.1M. The largest supplier is DENMARK ($157.8M, 23 shipments), followed by GREECE and CHINA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Liraglutide to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	DENMARK	$157.8M	23	98.0%
2	GREECE	$1.4M	6	0.9%
3	CHINA	$1.1M	21	0.7%
4	UNITED STATES	$466.7K	79	0.3%
5	CANADA	$116.3K	17	0.1%
6	UNITED KINGDOM	$45.4K	18	0.0%
7	AUSTRALIA	$41.4K	12	0.0%
8	GERMANY	$34.3K	11	0.0%
9	SOUTH AFRICA	$22.3K	6	0.0%
10	CZECH REPUBLIC	$5.0K	2	0.0%

Showing top 10 of 14 origin countries

DENMARK is the largest supplier of liraglutide to India, accounting for 98.0% of total import value. The top 5 origin countries — DENMARK, GREECE, CHINA, UNITED STATES, CANADA — together supply 99.9% of India's liraglutide imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Liraglutide

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, the FDA's Orange Book lists no approved Abbreviated New Drug Applications (ANDAs) for liraglutide, indicating the absence of generic versions in the U.S. market. The original New Drug Application (NDA) for liraglutide, marketed as Victoza, was approved on June 30, 2009. Given the limited export volume to the U.S. (0.7% of total exports), Indian manufacturers aiming to penetrate this market must navigate the FDA's stringent regulatory pathways, including the submission of an NDA or ANDA, adherence to Good Manufacturing Practices (GMP), and potential pre-approval inspections.

2EU & UK Regulatory Framework

The European Medicines Agency (EMA) granted marketing authorization for Victoza (liraglutide) on June 30, 2009, for the treatment of type 2 diabetes mellitus in adults, adolescents, and children aged 10 years and above. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) continues to recognize this authorization post-Brexit. Manufacturers exporting to these regions must comply with the EU's GMP standards, which encompass quality management, personnel qualifications, and facility requirements. Regular inspections ensure compliance, and any deviations can result in corrective actions or suspension of manufacturing licenses.

3WHO Essential Medicines & Global Standards

In September 2025, the World Health Organization (WHO) included GLP-1 therapies, such as liraglutide, in its 24th Model List of Essential Medicines for managing type 2 diabetes in high-risk groups. This inclusion underscores liraglutide's significance in global health. Manufacturers should ensure that their products meet the standards set forth in recognized pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), to facilitate international acceptance and compliance.

4India Regulatory Classification

In India, liraglutide is classified under Schedule H of the Drugs and Cosmetics Act, necessitating a prescription for its dispensation. The National Pharmaceutical Pricing Authority (NPPA) has not imposed a ceiling price on liraglutide as of March 2026, allowing market-driven pricing. For exports, manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations and facilitating smooth international trade.

5Patent & Exclusivity Status

The primary patent for liraglutide, held by Novo Nordisk, expired in 2022, opening the market to generic competition. However, the absence of approved ANDAs in the U.S. suggests that generic manufacturers are still in the process of navigating regulatory approvals. This presents an opportunity for Indian pharmaceutical companies to enter the market, provided they meet the requisite regulatory standards.

6Recent Industry Developments

In December 2025, the WHO issued its first guideline on the use of GLP-1 therapies, including liraglutide, for treating obesity as a chronic disease. This development is expected to increase global demand for liraglutide. Additionally, in April 2025, the WHO unveiled a global repository for National Essential Medicines Lists (nEMLs), providing a centralized platform that includes liraglutide, thereby facilitating its adoption in national healthcare systems. These developments highlight the growing recognition of liraglutide's therapeutic value and may influence regulatory policies and market dynamics globally.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Liraglutide

Retail & reference prices across 9 markets vs. India FOB export price of $35.91/unit

Global Price Benchmark for Liraglutide across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$1,030	USD	According to the FDA's Orange Book, Liraglutide is approved under the brand name Victoza for diabetes and Saxenda for weight management.
United Kingdom	$260	GBP	As per the NHS Drug Tariff, Liraglutide is listed under the brand names Victoza and Saxenda.
Germany	$275	EUR	The European Medicines Agency (EMA) has approved Liraglutide for use in the European Union under the brand names Victoza and Saxenda.
Australia	$225

Supply Chain Risk Assessment — Liraglutide

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is primarily manufactured in India for export. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) sourced from China. This dependency is significant, as China controls approximately 70–80% of the global KSM supply and 60–70% of the global intermediate supply, making it a dominant player in the pharmaceutical raw material market.

Recent disruptions have highlighted the vulnerabilities associated with this reliance. In early 2025, the FDA declared the shortage of semaglutide injection products resolved as of February 21, 2025, after a period of increased demand and supply constraints. Similarly, in 2023 and 2024, shortages of Victoza (liraglutide) occurred in some countries due to a temporary supply reduction and increased demand. (ema.europa.eu) These events underscore the risks associated with concentrated sourcing of critical raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a high supplier concentration in the export of liraglutide from India. The top five exporters account for 98.1% of the total export value, with SUN PHARMACEUTICAL INDUSTRIES LIMITED alone contributing 52.6%. This concentration poses a significant single-source risk, as any disruption affecting these key suppliers could severely impact the global supply chain.

Access Complete Liraglutide Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 416 transactions across 36 markets.

Request Demo View Pricing

Frequently Asked Questions — Liraglutide Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top liraglutide exporters from India?

The leading liraglutide exporters from India are SUN PHARMACEUTICAL INDUSTRIES LIMITED, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, LUPIN LIMITED, and 7 others. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 52.6% market share ($2.3M). The top 5 suppliers together control 98.1% of total export value.

What is the total export value of liraglutide from India?

The total export value of liraglutide from India is $4.3M, recorded across 416 shipments from 53 active exporters to 36 countries. The average shipment value is $10.3K.

Which countries import liraglutide from India?

India exports liraglutide to 36 countries. The top importing countries are BELGIUM (52.7%), SOUTH AFRICA (32.6%), HONG KONG (7.6%), SAUDI ARABIA (3.6%), UNITED STATES (0.7%), which together account for 97.2% of total export value.

What is the HS code for liraglutide exports from India?

The primary HS code for liraglutide exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Liraglutide

Liraglutide

Top Liraglutide Exporters from India

Top Countries Importing Liraglutide from India

Who Supplies Liraglutide to India?

Quick Facts

Related Diabetes & Endocrine

Related Analysis

Need Details?

Regulatory Landscape — Liraglutide

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Liraglutide

Supply Chain Risk Assessment — Liraglutide

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Liraglutide Trade Intelligence

Frequently Asked Questions — Liraglutide Exports from India

Who are the top liraglutide exporters from India?

What is the total export value of liraglutide from India?

Which countries import liraglutide from India?

What is the HS code for liraglutide exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of liraglutide exports from India?

Which ports handle liraglutide exports from India?

Why is India a leading exporter of liraglutide?

What certifications do Indian liraglutide exporters need?

How many buyers import liraglutide from India?

What is the market share of the top liraglutide exporter from India?

Analysis Methodology